Compared to Estimates, EverQuote (EVER) Q2 Earnings: A Look at Key Metrics
The headline numbers for EverQuote (EVER) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
EverQuote (EVER) Beats Q2 Earnings Estimates
EverQuote (EVER) came out with quarterly earnings of $0.39 per share, beating the Zacks Consensus Estimate of $0.35 per share. This compares to earnings of $0.17 per share a year ago.
EverQuote: Diversification Could Provide More Upside
EverQuote delivered record Q1 2025 results, with 83% revenue growth and strong cash flow, driven by a robust auto insurance vertical. The company's proprietary technology and AI-powered Smart Campaigns provide a competitive edge, improving campaign performance and driving higher-quality leads for partners. Heavy reliance on the auto insurance segment and third-party media sources poses concentration and cost risks, despite ongoing diversification efforts.
EVER Rallies 27% YTD, Trades at Premium: Should You Buy the Stock?
EverQuote gains 26.9% YTD, outperforming its industry as platform expansion and acquisitions fuel strong growth.
Bet on Winning DuPont Analysis & Pick 3 Top Stocks
EVER, MAMA, and SFM stand out in a DuPont-driven screen with strong profit margins, asset efficiency, and moderate leverage.
4 Growth Stocks From the Insurance Space to Add to Your Portfolio
Given the prospects of the insurance industry, EVER, HMN, ROOT and HCI have the potential to generate better returns than other players.
Bet on Winning DuPont Analysis & Pick 3 Top Stocks
Do you have more faith in DuPont analysis than simple ROE calculation? Tap EverQuote (EVER), Hims & Hers Health (HIMS) and Sprouts Farmers Market (SFM).
Enrich Your Portfolio With These 4 Top-Ranked Liquid Stocks
Add INTU, NVMI, EVER and SEZL to your watchlist as each boasts strong liquidity, growth attributes and operational efficiency.
Wall Street Analysts See a 38.85% Upside in EverQuote (EVER): Can the Stock Really Move This High?
The mean of analysts' price targets for EverQuote (EVER) points to a 38.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
EverQuote (EVER) Up 4.8% Since Last Earnings Report: Can It Continue?
EverQuote (EVER) reported earnings 30 days ago. What's next for the stock?
Bet on Winning DuPont Analysis & Pick 3 Top Stocks
Do you have more faith in DuPont analysis than simple ROE calculation? Tap EverQuote (EVER), Hims & Hers Health (HIMS) and Sprouts Farmers Market (SFM).
Add These 4 Top-Ranked Liquid Stocks to Boost Portfolio Returns
Boost returns with liquid, efficient top-ranked stocks like NEM, PGY, EVER and SEZL, each of which is backed by strong growth and financial metrics.
